Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis

Ruchika Goel, Matthew Morgan, Dimitrios Chanouzas, Joshua Caplan, Sarah Logan, Lorraine Harper

Research output: Contribution to journal › Article › peer-review

60 Downloads (Pure)

Original language	English
Article number	rkab039
Journal	Rheumatology Advances in Practice
Volume	5
Issue number	2
Early online date	16 Jul 2021
DOIs	https://doi.org/10.1093/rap/rkab039
Publication status	Published - 2021

Access to Document

@article{fa35a1e4c4e449f48ab4d34189e087b1,

title = "Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis",

author = "Ruchika Goel and Matthew Morgan and Dimitrios Chanouzas and Joshua Caplan and Sarah Logan and Lorraine Harper",

year = "2021",

doi = "10.1093/rap/rkab039",

language = "English",

volume = "5",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis

AU - Goel, Ruchika

AU - Morgan, Matthew

AU - Chanouzas, Dimitrios

AU - Caplan, Joshua

AU - Logan, Sarah

AU - Harper, Lorraine

PY - 2021

Y1 - 2021

U2 - 10.1093/rap/rkab039

DO - 10.1093/rap/rkab039

M3 - Article

C2 - 34632259

SN - 2514-1775

VL - 5

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

IS - 2

M1 - rkab039

ER -